Nuzenio

First Dosing

First Dosing news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Theriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:44:00 GMT Theriva™ Biologics Announces First Patient Dosed in VIRAGE2 - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 12:00:00 GMT Theriva’s Six-Patient Cancer Trial Is Designed to Test Repeat Virus Dosing - stocktitan.netstocktitan.net · Thu, 06 Aug 2026 12:00:00 GMT Ractigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 11:56:14 GMT Migraine Biotech Doses First Patient in Phase 2b EVO756 Trial - Streetwise ReportsStreetwise Reports · Thu, 06 Aug 2026 09:41:48 GMT Oblenio doses first patients in phase 1a autoimmune trial - PharmaTimesPharmaTimes · Wed, 05 Aug 2026 10:33:53 GMT Curis Doses First Five Patients in TakeAim CLL Study - PR NewswirePR Newswire · Thu, 30 Jul 2026 07:00:00 GMT Oak Hill Bio Announces Dosing of First Participant in - GlobeNewswireGlobeNewswire · Tue, 28 Jul 2026 12:00:00 GMT

Timeline

Fri, 07 Aug 2026 06:44:00 GMTTheriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - The Clinical Trial Vanguard

Thu, 06 Aug 2026 12:00:00 GMTTheriva™ Biologics Announces First Patient Dosed in VIRAGE2 - GlobeNewswire

Thu, 06 Aug 2026 12:00:00 GMTTheriva’s Six-Patient Cancer Trial Is Designed to Test Repeat Virus Dosing - stocktitan.net

Thu, 06 Aug 2026 11:56:14 GMTRactigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS - The Manila Times

Thu, 06 Aug 2026 09:41:48 GMTMigraine Biotech Doses First Patient in Phase 2b EVO756 Trial - Streetwise Reports

Wed, 05 Aug 2026 10:33:53 GMTOblenio doses first patients in phase 1a autoimmune trial - PharmaTimes

Related explainers

HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

Trial7 live mentions First Patient6 live mentions Phase6 live mentions The Clinical Trial3 live mentions Theriva3 live mentions Dosing3 live mentions Patient3 live mentions VCN2 live mentions Metastatic Pancreatic Cancer2 live mentions Biologics Announces First2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for First Dosing.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.